Hepatocellular Carcinoma Risk After Direct‐Acting Antiviral Therapy
Feng Su, George N. Ioannou – 21 February 2019
Phenobarbital‐Induced Liver Injury With Nodal Angiomatosis
Li‐Ting Cheng, Matthew M. Yeh, Chun‐Chi Lu – 21 February 2019
What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma?
Neil Mehta, Francis Y. Yao – 21 February 2019
Hepatocellular Carcinoma Risk After Direct‐Acting Antiviral Therapy
Feng Su, George N. Ioannou – 21 February 2019
Surveillance and Diagnosis of Hepatocellular Carcinoma
Jane Lim, Amit G. Singal – 21 February 2019
The Spectrum of Hepatic Involvement in Patients With Telomere Disease
Devika Kapuria, Gil Ben‐Yakov, Rebecca Ortolano, Min Ho Cho, Or Kalchiem‐Dekel, Varun Takyar, Shilpa Lingala, Naveen Gara, Michele Tana, Yun Ju Kim, David E. Kleiner, Neal S. Young, Danielle M. Townsley, Christopher Koh, Theo Heller – 21 February 2019 – Loss‐of‐function mutations in genes that encode for components of the telomere repair complex cause accelerated telomere shortening. Hepatic involvement has been recognized as a cause of morbidity in telomere diseases, but very few studies have characterized the nature and extent of liver involvement in affected patients.
The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B
Laifeng Ren, Ming Zeng, Zizhi Tang, Mingyuan Li, Xiaojun Wang, Yang Xu, Yuding Weng, Xiaobo Wang, Huan Wang, Liandi Guo, Bing Zuo, Xin Wang, Si Wang, Jiangyan Lou, Yaxiong Tang, Dezhi Mu, Ning Zheng, Xianhui Wu, Junhong Han, Antony M. Carr, Penelope Jeggo, Cong Liu – 21 February 2019 – Chronic infection of hepatitis B virus (HBV) is associated with an increased incidence of hepatocellular carcinoma (HCC).
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero, Laura M. Kulik, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michael M. Abecassis, Lewis R. Roberts, Julie K. Heimbach – 21 February 2019